One of the reasons (after the tax issue) that Pfizer wanted AstraZ was AZN's oncology pipeline. Ergo, some logic in Pfizer looking at Ariad... though my guess is that we are too small for Pfizer's appetite.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.